Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Italian launch for Prograf announced

July 15, 1998

WF10, a unique AIDS treatment alternative evaluated in the clinic

July 13, 1998

Immunosuppressive potassium channel blockers from Merck & Co.

July 9, 1998

Multiantigen malaria vaccine evaluated in phase I/II study

July 8, 1998

New immunosuppressants from Merck & Co. acting on potassium channels

July 8, 1998

Chugai to begin clinical testing of anti-IL-6 receptor antibody

July 6, 1998

Asta Medica investigates compounds for immune and allergic disorders

July 1, 1998

Human Genome Sciences presents novel chemokine, its preparation and use

July 1, 1998

Astra devotes significant resources to development of immunomodulatory peptides

June 30, 1998

Astra prepares another series of immunomodulatory peptides

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...